Shares of Senseonics Holdings jumped 47.1% in Wednesday's extended market trading after the medical technology company raised its 4Q sales guidance by 40% to $3.5 million. Earlier, the company had projected revenues of $2.5 million for the quarter. Senseonics (SENS) CEO Tim Goodnow said, "Strong fourth quarter performance was driven by sales in Europe and supported by Ascensia’s initial US sales.” The company reiterated its revenue guidance for 2021. Next year, Senseonics expects to generate revenue of between $12 million and $15 million. The company said that its 2021 sales outlook is “based on installed base, acceleration of Ascensia’s commercial activities and other factors.